Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐line treatment regimen for unresectable pancreatic cancer: A real‐world analysis

BACKGROUND: Although second‐line treatment for pancreatic cancer has been proven to have survival benefit, it is not clear which is the most preferred regimen. This study compared the efficacy and safety of modified FOLFIRINOX (mFOLFIRINOX) and sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐li...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Shun, Ueno, Makoto, Oishi, Ritsuko, Nagashima, Shuhei, Sano, Yusuke, Kawano, Kuniyuki, Tanaka, Satoshi, Fukushima, Taito, Asama, Hiroyuki, Konno, Naoki, Kobayashi, Satoshi, Morimoto, Manabu, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855892/
https://www.ncbi.nlm.nih.gov/pubmed/34953056
http://dx.doi.org/10.1002/cam4.4512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855892/
https://www.ncbi.nlm.nih.gov/pubmed/34953056
http://dx.doi.org/10.1002/cam4.4512

Ejemplares similares